Skip to main content
OpenTrials

Clinical trial condition

Castration-Resistant Prostate Cancer (CRPC)

Explore clinical trials studying Castration-Resistant Prostate Cancer (CRPC). Study availability and eligibility vary by location and protocol.

7 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

Castration-Resistant Prostate Cancer (CRPC) trial results

Recruiting

Study of Oral MRT-2359 With Apalutamide in Prostate Cancer

NCT07745361

Conditions
Adenocarcinoma, Carcinoma, Castration-Resistant Prostate Cancer (CRPC), +15 more
Locations
  • START Los Angeles Los Angeles, California, United States
  • Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
  • Rocky Mountain Cancer Center Colorado Springs, Colorado, United States
  • Kansas University Cancer Center Kansas City, Kansas, United States
View all 14 locations
View Trial Details
Recruiting

A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors

NCT07540572

Conditions
Brain Diseases, Bronchial Neoplasms, Carcinoma, Bronchogenic, +30 more
Locations
  • Florida Clinical Trials Group Plantation, Florida, United States
  • START Astera, LLC East Brunswick, New Jersey, United States
  • START New York Long Island, LLC Lake Success, New York, United States
  • NEXT Texas LLC - Austin Austin, Texas, United States
View Trial Details
Completed

A Study to Assess the Safety of Continued Administration of MDV3100 in Subjects With Prostate Cancer Who Showed Benefit From Prior Exposure to MDV3100

NCT01534052

Conditions
Castration-Resistant Prostate Cancer (CRPC), Genital Diseases, Genital Diseases, Male, +8 more
Locations
  • Site US107 Aurora, Colorado, United States
  • Site US104 Chicago, Illinois, United States
  • Site US105 Pittsburgh, Pennsylvania, United States
  • Site US106 San Antonio, Texas, United States
View Trial Details

Related conditions